Home LiteratureArticle Details
PMID: 9419364 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Heteroclitic proliferative responses and changes in cytokine profile induced by altered peptides: implications for autoimmunity.

Nicholson LB, Waldner H, Carrizosa AM, Sette A, Collins M, Kuchroo VK

Abstract

Productive engagement of T cell receptors (TCRs) by cognate ligand (major histocompatibility complex plus peptide) leads to proliferation, differentiation, and the elaboration of effector functions. Altered peptides generated by single amino acid substitutions in the antigenic peptide have diverse effects on the outcome of the T cell response. We have generated an altered peptide (Q144) from an autoantigenic peptide of myelin proteolipid protein 139-151 by a single amino acid substitution (from tryptophan to glutamine) in the primary TCR contact at position 144 that is capable of inducing CD4(+) T cell responses in H-2(s) mice. By using a Q144-specific T cell clone (Q1.1B6), we see a hierarchy in T cell proliferation and cytokine production with various position 144 substituted peptides and have identified a peptide (L144) that hyperstimulates this T cell clone. In contrast to Q144, L144 induces maximal proliferation at 7 logs lower antigen concentration, induces greater cell death at higher antigen dose, and induces the secretion of cytokines not detected following stimulation with the cognate ligand. This heteroclitic T cell response associated with changes in cytokine profile was observed with several other T cell clones of different specificities. The L144 peptide also induces costimulation independent proliferation and cytokine production from the Q1.1B6 T cell clone. We describe this as a superagonist response. Such responses may have a role in the initiation of autoimmunity by promoting a proinflammatory environment following ligation of a cross-reactive TCR on autoreactive T cells.

MeSH Terms
Amino Acid Sequence Animals Autoimmunity/physiology CHO Cells Cell Division Clone Cells/metabolism Cricetinae Cytokines/metabolism Female Mice Molecular Sequence Data Receptors, Antigen, T-Cell, alpha-beta/metabolism
Chemicals
Cytokines Receptors, Antigen, T-Cell, alpha-beta
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Nicholson L B
Center for Neurologic Diseases, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA.
Waldner H
Carrizosa A M
Sette A
Collins M
Kuchroo V K
References (40)
40 references, click to expand
  1. T cell receptor alpha-chain defines the antigen specificity of antigen-specific suppressor factor but does not impart genetic restriction.
    J Immunol. 1995 Mar 1;154(5):2075-81 PMID: 7868884
  2. Characterization of the specificity of peptide binding to four DR haplotypes.
    J Immunol. 1990 Sep 15;145(6):1799-808 PMID: 2167910
  3. Altered peptide ligands can control CD4 T lymphocyte differentiation in vivo.
    J Exp Med. 1995 Apr 1;181(4):1569-74 PMID: 7699337
  4. Manipulation of the Th1/Th2 balance in autoimmune disease.
    Curr Opin Immunol. 1996 Dec;8(6):837-42 PMID: 8994864
  5. The T-cell-receptor repertoire in the synovial fluid of a patient with rheumatoid arthritis is polyclonal.
    Proc Natl Acad Sci U S A. 1991 Oct 1;88(19):8534-8 PMID: 1656449
  6. Separation of IL-4 production from Th cell proliferation by an altered T cell receptor ligand.
    Science. 1991 May 31;252(5010):1308-10 PMID: 1833816
  7. Antigen analog-major histocompatibility complexes act as antagonists of the T cell receptor.
    Cell. 1992 Feb 21;68(4):625-34 PMID: 1739971
  8. Disease inhibition by major histocompatibility complex binding peptide analogues of disease-associated epitopes: more than blocking alone.
    J Exp Med. 1992 Sep 1;176(3):667-77 PMID: 1380974
  9. Costimulation of T lymphocytes: the role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy.
    Cell. 1992 Dec 24;71(7):1065-8 PMID: 1335362
  10. Peptide-major histocompatibility complex class II complexes with mixed agonist/antagonist properties provide evidence for ligand-related differences in T cell receptor-dependent intracellular signaling.
    J Exp Med. 1993 Apr 1;177(4):1047-60 PMID: 8384651
  11. The role of the CD28 receptor during T cell responses to antigen.
    Annu Rev Immunol. 1993;11:191-212 PMID: 8386518
  12. Induction of T-cell anergy by altered T-cell-receptor ligand on live antigen-presenting cells.
    Nature. 1993 May 13;363(6425):156-9 PMID: 8483498
  13. Cytokines and adhesion molecules contribute to the ability of myelin proteolipid protein-specific T cell clones to mediate experimental allergic encephalomyelitis.
    J Immunol. 1993 Oct 15;151(8):4371-82 PMID: 7691946
  14. Positive selection of lymphocytes.
    Cell. 1994 Jan 28;76(2):219-28 PMID: 8293460
  15. Negative selection of lymphocytes.
    Cell. 1994 Jan 28;76(2):229-39 PMID: 8293461
  16. Lymphocyte responses and cytokines.
    Cell. 1994 Jan 28;76(2):241-51 PMID: 7904900
  17. T cell receptor antagonist peptides are highly effective inhibitors of experimental allergic encephalomyelitis.
    Eur J Immunol. 1994 Apr;24(4):940-6 PMID: 7512036
  18. Lymphokine production by human T cells in disease states.
    Annu Rev Immunol. 1994;12:227-57 PMID: 8011282
  19. Tolerance, danger, and the extended family.
    Annu Rev Immunol. 1994;12:991-1045 PMID: 8011301
  20. Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis.
    Science. 1994 Aug 26;265(5176):1237-40 PMID: 7520605
  21. A single TCR antagonist peptide inhibits experimental allergic encephalomyelitis mediated by a diverse T cell repertoire.
    J Immunol. 1994 Oct 1;153(7):3326-36 PMID: 7522258
  22. Cytokine transcriptional events during helper T cell subset differentiation.
    J Exp Med. 1996 Aug 1;184(2):397-406 PMID: 8760793
  23. Major histocompatibility complex binding affinity of an antigenic determinant is crucial for the differential secretion of interleukin 4/5 or interferon gamma by T cells.
    Proc Natl Acad Sci U S A. 1995 Oct 10;92(21):9510-4 PMID: 7568164
  24. Modifications of peptide ligands enhancing T cell responsiveness imply large numbers of stimulatory ligands for autoreactive T cells.
    J Immunol. 1997 Apr 15;158(8):3746-52 PMID: 9103439
  25. Identification of high potency microbial and self ligands for a human autoreactive class II-restricted T cell clone.
    J Exp Med. 1997 May 5;185(9):1651-9 PMID: 9151902
  26. Characterization and quantitation of peptide-MHC complexes produced from hen egg lysozyme using a monoclonal antibody.
    Immunity. 1997 Jun;6(6):727-38 PMID: 9208845
  27. A T cell receptor antagonist peptide induces T cells that mediate bystander suppression and prevent autoimmune encephalomyelitis induced with multiple myelin antigens.
    Proc Natl Acad Sci U S A. 1997 Aug 19;94(17):9279-84 PMID: 9256473
  28. Single cell analysis reveals regulated hierarchical T cell antigen receptor signaling thresholds and intraclonal heterogeneity for individual cytokine responses of CD4+ T cells.
    J Exp Med. 1997 Aug 29;186(5):757-66 PMID: 9271591
  29. Autopathogenic T helper cell type 1 (Th1) and protective Th2 clones differ in their recognition of the autoantigenic peptide of myelin proteolipid protein.
    J Exp Med. 1997 Sep 15;186(6):867-76 PMID: 9294141
  30. An altered peptide ligand mediates immune deviation and prevents autoimmune encephalomyelitis.
    Immunity. 1995 Oct;3(4):397-405 PMID: 7584131
  31. Neuroantigen-specific Th2 cells are inefficient suppressors of experimental autoimmune encephalomyelitis induced by effector Th1 cells.
    J Immunol. 1995 Nov 15;155(10):5011-7 PMID: 7594508
  32. Mouse T-cell receptor variable gene segment families.
    Immunogenetics. 1995;42(6):501-30 PMID: 8550093
  33. Treatment of experimental encephalomyelitis with a peptide analogue of myelin basic protein.
    Nature. 1996 Jan 25;379(6563):343-6 PMID: 8552189
  34. Essential flexibility in the T-cell recognition of antigen.
    Nature. 1996 Apr 11;380(6574):495-8 PMID: 8606766
  35. T cell activation determined by T cell receptor number and tunable thresholds.
    Science. 1996 Jul 5;273(5271):104-6 PMID: 8658175
  36. Peptide analogs with different affinites for MHC alter the cytokine profile of T helper cells.
    Int Immunol. 1996 May;8(5):745-55 PMID: 8671663
  37. Tracking antigen-specific helper T cell responses.
    Curr Opin Immunol. 1996 Apr;8(2):278-84 PMID: 8725952
  38. Antigen presentation by chemically modified splenocytes induces antigen-specific T cell unresponsiveness in vitro and in vivo.
    J Exp Med. 1987 Feb 1;165(2):302-19 PMID: 3029267
  39. T cell recognition as the target for immune intervention in autoimmune disease.
    Cell. 1989 Jun 2;57(5):709-15 PMID: 2655929
  40. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy.
    Cell. 1995 Mar 10;80(5):707-18 PMID: 7534215
Article Info
Journal
Proceedings of the National Academy of Sciences of the United States of America
Abbr.
Proc Natl Acad Sci U S A
ISSN
0027-8424
Published
1998-01-06
Pages
264-9
Language
English
Region
United States
NLM ID
7505876
PMCID
PMC18196
Subset
IM
Grants
NINDS NIH HHS · R01 NS030843 · United States
NIAID NIH HHS · P01AI39671-01A1 · United States
NINDS NIH HHS · NS30843 · United States
NIAID NIH HHS · P01 AI039671 · United States
NINDS NIH HHS · R37 NS030843 · United States
NINDS NIH HHS · R01 NS035685 · United States
NINDS NIH HHS · R01NS35685 · United States
NINDS NIH HHS · R29 NS030843 · United States
Databases
GENBANK
AF037038, AF037039
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]